The infertility treatment market has witnessed significant growth, with various segments contributing to its expansion. The global market is estimated to reach USD 1.70 billion in 2024 and is expected to grow to USD 3.65 billion by 2034, expanding at a CAGR of 7.9% during the forecast period. This growth is primarily driven by the increasing desire for parenthood and the rising demand for infertility treatments. In this article, we delve into the key segments of the market, focusing on the equipment, assisted reproductive technology (ART), female infertility treatment, and fertility centers, each playing a vital role in shaping the future of infertility care.
Get All the Details in Our Solution – Download Brochure @ https://www.towardshealthcare.com/download-brochure/5116
The equipment segment emerged as the dominant player in the infertility treatment market in 2023 and is projected to grow at the fastest rate during the forecast period. This segment encompasses a wide range of devices and tools required for various infertility treatments. From diagnostic tools to advanced machinery used during procedures, equipment is essential for the success of infertility treatments.
Technological advancements and an increase in research and development activities are driving the innovation of new and more efficient equipment. The growing demand for in vitro fertilization (IVF) and other infertility procedures is further boosting the need for specialized devices, propelling the equipment segment’s growth. As technological capabilities expand, the demand for more sophisticated tools and equipment is expected to rise, reinforcing this segment’s position as the market leader.
By procedure, Assisted Reproductive Technology (ART) stood as the leading segment in 2023. ART refers to a series of fertility treatments that involve the manipulation of eggs or embryos outside the body. The most common ART procedure is in vitro fertilization (IVF), accounting for approximately 99% of all ART cycles globally. With over 3 million ART cycles reported annually worldwide, this segment is a cornerstone of the infertility treatment market.
The growing success rates of ART procedures, driven by scientific advancements in fertility treatments, contribute significantly to the segment’s dominance. IVF, in particular, is increasingly preferred by patients due to its high success rates and continuous improvements in techniques that enhance outcomes. The ART segment’s ability to provide viable solutions for couples struggling with infertility continues to drive its growth.
When considering patient type, the female infertility treatment segment held the largest share of the market in 2023. Female infertility, which refers to a woman’s inability to conceive after a year of trying, is responsible for around 30% of fertility problems. Factors such as ovulation disorders, polycystic ovary syndrome (PCOS), and other health conditions are major contributors to female infertility, which has led to an increase in treatment demand.
The growing prevalence of fertility issues among women and the availability of advanced treatments are key factors fueling the growth of the female infertility treatment segment. The desire to have children, coupled with social pressures and the ability to address long-term fertility concerns, has led many women to seek medical intervention, further boosting the market for female infertility treatments.
By end-user, the fertility centers segment led the market in 2023. Fertility centers have become essential players in providing specialized care for individuals seeking infertility treatments. The growth of this segment can be attributed to several factors, including the presence of skilled medical professionals, state-of-the-art infrastructure, and the availability of specialized equipment necessary for ART procedures.
The increasing number of fertility centers, combined with the growing patient base seeking assistance for fertility issues, is fueling the segment’s expansion. These centers are equipped to provide a wide range of services, from initial consultations and diagnosis to complex fertility procedures like IVF and egg retrieval. As more people turn to fertility centers for infertility treatments, this segment is poised for continued growth.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/infertility-treatment-market-sizing
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5116
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More